Most of the time, more than 95%, no surgery is needed
Diabetologia (2005) This randomized, double-blind, placebo-controlled crossover study evaluated the effects of pramlintide on satiety and food intake in two populations: 11 insulin-treated men with type 2 diabetes (mean BMI 28.9) and 15 obese non-diabetic men (mean BMI 34.4)
Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist
Here's what confuses most people: they assume IM is 'stronger' because it feels more clinical
Funding National Natural Science Foundation of China, Grant/Award Numbers: 81571709, 81971650
(6) M H Rasmussen, J Frystyk, T Andersen, L Breum, et al (1994) The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone Metabolism, 1994 Mar, Volume 43 (Issue 3), Pages 315-9